(Q52710300)

6 May 2018

title

Involvement of breast cancer resistance protein (BCRP/ABCG2) in the secretion of danofloxacin into milk: interaction with ivermectin. (English)

1 reference

6 May 2018

0 references

5

1 reference

6 May 2018

Ana I. Alvarez

7

1 reference

6 May 2018

Gracia Merino

8

1 reference

6 May 2018

author name string

R Real

1

1 reference

6 May 2018

E Egido

2

1 reference

6 May 2018

M Pérez

3

1 reference

6 May 2018

L González-Lobato

4

1 reference

6 May 2018

J G Prieto

6

1 reference

6 May 2018

publication date

11 October 2010

1 reference

6 May 2018

Journal of Veterinary Pharmacology and Therapeutics

published in

1 reference

6 May 2018

volume

34

1 reference

6 May 2018

page(s)

313-321

1 reference

6 May 2018

issue

4

1 reference

6 May 2018

Fluoroquinolone efflux mediated by ABC transporters.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2010.01241.X

Involvement of breast cancer resistance protein (ABCG2) in the biliary excretion mechanism of fluoroquinolones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2010.01241.X

Use of P-glycoprotein and BCRP inhibitors to improve oral bioavailability and CNS penetration of anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2010.01241.X

Development of a method for the determination of danofloxacin in plasma by HPLC with fluorescence detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2010.01241.X

Substrate-dependent breast cancer resistance protein (Bcrp1/Abcg2)-mediated interactions: consideration of multiple binding sites in in vitro assay design

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2010.01241.X

The function of breast cancer resistance protein in epithelial barriers, stem cells and milk secretion of drugs and xenotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2010.01241.X

Breast cancer resistance protein (Bcrp1/Abcg2) reduces systemic exposure of the dietary carcinogens aflatoxin B1, IQ and Trp-P-1 but also mediates their secretion into breast milk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2010.01241.X

Multidrug transporter ABCG2/breast cancer resistance protein secretes riboflavin (vitamin B2) into milk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2010.01241.X

The breast cancer resistance protein BCRP (ABCG2) concentrates drugs and carcinogenic xenotoxins into milk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2010.01241.X

Combined use of ivermectin and triclabendazole in sheep: in vitro and in vivo characterisation of their pharmacological interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2010.01241.X

Pharmacokinetics and penetration of danofloxacin into the gastrointestinal tract in healthy and in Salmonella typhimurium infected pigs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2010.01241.X

Multiresidue determination of fluoroquinolones in milk by column liquid chromatography with fluorescence and ultraviolet absorbance detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2010.01241.X

Pharmacokinetics and tissue disposition of danofloxacin in sheep.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2010.01241.X

The breast cancer resistance protein (BCRP/ABCG2) affects pharmacokinetics, hepatobiliary excretion, and milk secretion of the antibiotic nitrofurantoin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2010.01241.X

Breast cancer resistance protein (BCRP/ABCG2) transports fluoroquinolone antibiotics and affects their oral availability, pharmacokinetics, and milk secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2010.01241.X

Natural allelic variants of bovine ATP-binding cassette transporter ABCG2: increased activity of the Ser581 variant and development of tools for the discovery of new ABCG2 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2010.01241.X

Mass drug treatment for lymphatic filariasis and onchocerciasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2010.01241.X

Characterization of substrates and inhibitors for the in vitro assessment of Bcrp mediated drug-drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2010.01241.X

Involvement of multidrug resistance-associated protein 2 in intestinal secretion of grepafloxacin in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2010.01241.X

Functions of the breast cancer resistance protein (BCRP/ABCG2) in chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2010.01241.X

Human breast cancer resistance protein: interactions with steroid drugs, hormones, the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine, and transport of cimetidine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2010.01241.X

In vitro and in vivo interaction of moxidectin with BCRP/ABCG2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2010.01241.X

Milk secretion of nitrofurantoin, as a specific BCRP/ABCG2 substrate, in assaf sheep: modulation by isoflavones

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2010.01241.X

Evaluation of the efficacy of systemic danofloxacin in the treatment of induced acute Escherichia coli bovine mastitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2010.01241.X

Differential involvement of multidrug resistance-associated protein 1 and P-glycoprotein in tissue distribution and excretion of grepafloxacin in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2010.01241.X

Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2010.01241.X

Danofloxacin-mesylate is a substrate for ATP-dependent efflux transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2010.01241.X

Implications of ABC transporters on the disposition of typical veterinary medicinal products

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2010.01241.X

Cloning, sequence and functional analysis of goat ATP-binding cassette transporter G2 (ABCG2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2010.01241.X

The breast cancer resistance protein (Bcrp1/Abcg2) limits fetal distribution of glyburide in the pregnant mouse: an Obstetric-Fetal Pharmacology Research Unit Network and University of Washington Specialized Center of Research Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2010.01241.X

10.1111/J.1365-2885.2010.01241.X

21 January 2018

Identifiers

DOI

1 reference

6 May 2018

PubMed ID

20950350

1 reference

6 May 2018